Alert detail
LCD L39654: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy — Palmetto GBA
What changed
Palmetto covers molecular biomarkers for indeterminate lung nodules post-broncho
Who’s affected: Pulmonology billing teams · Effective: September 22, 2024
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.